AlphaGrep UK’s Celestica CLS Stock Holding History

AlphaGrep UK’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Sell	556 -689	-55%	-$259K	0.06%	680
2026 Q1	$351K	Buy	+1,245	New	+$361K	0.1%	435

Other funds holding CLS

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

AlphaGrep UK's CLS Position: Q2 2026 in Review

AlphaGrep UK reduced its Celestica (CLS) stake by 55% in Q2 2026, selling an estimated $259K and leaving 556 shares worth $203K. The position accounts for 0.06% of the portfolio, ranked #680.

AlphaGrep UK first reported a position in CLS in Q1 2026 and has held it in 2 quarters since. The position peaked at $351K in Q1 2026. 826 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

AlphaGrep UK held 556 shares of Celestica worth $203K as of Q2 2026.
AlphaGrep UK sold 689 Celestica shares in Q2 2026, an estimated $259K.
Celestica made up 0.06% of AlphaGrep UK's portfolio in Q2 2026, its #680 holding.
AlphaGrep UK first reported a position in Celestica in Q1 2026 and has held it in 2 quarters since.
AlphaGrep UK's Celestica position peaked at $351K in Q1 2026.
826 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.